Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.
Type:
Grant
Filed:
June 3, 2005
Date of Patent:
April 1, 2008
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Xiaoli Chen, Keith T. Demarest, Jung Lee, Jay M. Matthews, Philip Rybczynski